- Home
- HKPD vs CVM Comparison
HKPD vs CVM Comparison
Compare HKPD & CVM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HKPD
- CVM
- Stock Information
- Founded
- HKPD 2016
- CVM 1983
- Country
- HKPD Hong Kong
- CVM United States
- Employees
- HKPD N/A
- CVM N/A
- Industry
- HKPD Other Pharmaceuticals
- CVM Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- HKPD Health Care
- CVM Health Care
- Exchange
- HKPD Nasdaq
- CVM Nasdaq
- Market Cap
- HKPD 20.9M
- CVM 18.1M
- IPO Year
- HKPD 2025
- CVM 1987
- Fundamental
- Price
- HKPD $1.07
- CVM $8.70
- Analyst Decision
- HKPD
- CVM
- Analyst Count
- HKPD 0
- CVM 0
- Target Price
- HKPD N/A
- CVM N/A
- AVG Volume (30 Days)
- HKPD 70.4K
- CVM 551.0K
- Earning Date
- HKPD 01-01-0001
- CVM 08-14-2025
- Dividend Yield
- HKPD N/A
- CVM N/A
- EPS Growth
- HKPD N/A
- CVM N/A
- EPS
- HKPD 0.21
- CVM N/A
- Revenue
- HKPD $20,770,344.00
- CVM N/A
- Revenue This Year
- HKPD N/A
- CVM N/A
- Revenue Next Year
- HKPD N/A
- CVM N/A
- P/E Ratio
- HKPD $4.97
- CVM N/A
- Revenue Growth
- HKPD 32.91
- CVM N/A
- 52 Week Low
- HKPD $0.81
- CVM $1.98
- 52 Week High
- HKPD $3.79
- CVM $39.30
- Technical
- Relative Strength Index (RSI)
- HKPD N/A
- CVM 62.27
- Support Level
- HKPD N/A
- CVM $6.84
- Resistance Level
- HKPD N/A
- CVM $8.59
- Average True Range (ATR)
- HKPD 0.00
- CVM 1.32
- MACD
- HKPD 0.00
- CVM -0.14
- Stochastic Oscillator
- HKPD 0.00
- CVM 54.55
About HKPD Hong Kong Pharma Digital Technology Holdings Limited Ordinary shares
Hong Kong Pharma Digital Technology Holdings Ltd operates in two main categories: (i) OTC pharmaceutical cross-border e-commerce supply chain services, conducted through its Hong Kong subsidiary, Joint Cross Border, which it refers to as the Supply Chain Services division, and (ii) OTC pharmaceutical cross-border procurement and distribution, conducted through its Hong Kong subsidiary, V-Alliance, which it referred to as the Procurement and Distribution division. Based in Hong Kong, Joint Cross Border has established itself as a provider of third-party supply chain services in Mainland China's OTC pharmaceutical cross-border e-commerce market.
About CVM Cel-Sci Corporation
CEL-SCI Corp is a player in the biotechnology sector. It is engaged in the research and development of the treatment of cancer and other diseases using the immune system. The Company's core capabilities include drug discovery, research, development, and manufacturing of complex biological substances. It is focused on the development of Multikine (Leukocyte Interleukin, Injection), investigational immunotherapy under development for the treatment of certain head and neck cancers, and anal warts or cervical dysplasia.